Compare Godaddy Inc (GDDY) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Godaddy Inc vs Repligen Corporation Common Stock — how do they compare? Godaddy Inc trades at $103.39 (market cap $13.05B), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B). The key difference: Godaddy Inc is the larger of the two by market cap, and Repligen Corporation Common Stock is trading nearer its 52-week high, Godaddy Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Godaddy Inc for 65 Days and Repligen Corporation Common Stock for 0 Days on average.
| GDDY | RGEN | |
|---|---|---|
Market Cap | $13.05B | $11.14B |
Volume | 1,123,303 | 1,259,263 |
Sector | Technology | Health |
52-Week High | $135.18 | $194.57 |
52-Week Low | $75.07 | $102.87 |
Typical Hold Time | 65 Days | 0 Days |
Enterprise Value | $15.73B | $11.02B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GoDaddy (GDDY) trades at $103.36, up 1.02% today, with a bullish technical signal from moving averages. The company reported revenue of $4.95B in 2025 and net income of $875M, with consistent earnings beats in recent quarters. However, the stock faces headwinds from a securities class action lawsuit alleging misrepresentations about domain contract terms, as reported by multiple law firms in late September 2026.
The outlook is mixed: strong profitability and earnings momentum support upside, but legal risks and a consensus price target below the current price suggest caution. Investors should weigh robust fundamentals against litigation overhangs and monitor Q3 2026 earnings for further direction.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Godaddy Inc
GoDaddy is a provider of domain registration and aftermarket services, website hosting, security, design, and business productivity tools, commerce solutions, and domain registry services. The company primarily targets micro- to small businesses, website design professionals, registrar peers, and domain investors. Since acquiring payment processing platform Poynt in 2021, the company has expanded into omnicommerce solutions, including offering an online payment gateway and offline point-of-sale devices.
Read more on GDDY →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
